RecruitingN/AOther

National Pregnancy Registry for Psychiatric Medications

Sponsored by Massachusetts General Hospital

NCT ID
NCT01246765
Target Enrollment
5,000 participants
Start Date
2008-11
Est. Completion
2033-12

About This Study

The National Pregnancy Registry for Psychiatric Medications is dedicated to evaluating the safety of psychiatric medications such as antidepressants, ADHD medications, sedative hypnotics, and atypical antipsychotics that many people take during pregnancy to treat a wide range of mood, anxiety, executive function, or psychiatric disorders. The goal of this Registry is to gather information on the safety of these medications during pregnancy, as current data is limited.

Conditions Studied

Pregnant WomenPsychotropic Drugs

Eligibility

Sex:FEMALE
Age:18 Years - 45 Years
Healthy Volunteers:Yes
View full eligibility criteria
Inclusion Criteria:

* Pregnant women
* Age 18-45
* Subjects will be willing to participate over the phone
* Subjects will be able to provide informed consent

Exclusion Criteria:

* Women who have completed their pregnancy
* Women who are planning to become pregnant
* Women who are not taking any psychiatric medications and/or have no history of psychiatric illness

Study Locations (1)

Massachusetts General Hospital
Boston, Massachusetts, United States

Interested in this trial?

Contact the study team to learn more about eligibility and enrollment.

View on ClinicalTrials.gov
Data Source
ClinicalTrials.gov

Last updated from source

National Pregnancy Registry for Psychiatric Medications | Huxley